PQ 389
389. Deputy Micheál Martin asked the Minister for Health if the HSE has received an application for funding for the oral chemotherapy agent osimertinib; and if he will make a statement on the matter. [43393/19]
Introduced
22 October 2019
Last action
22 October 2019 · Medicinal Products Reimbursement
Status
written
Sponsors
Micheál Martin
Subjects
Discovery layer
Source updated
22 October 2019
Summary
389. Deputy Micheál Martin asked the Minister for Health if the HSE has received an application for funding for the oral chemotherapy agent osimertinib; and if he will make a statement on the matter. [43393/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 October 2019
Medicinal Products Reimbursement
389. Deputy Micheál Martin asked the Minister for Health if the HSE has received an application for funding for the oral chemotherapy agent osimertinib; and if he will make a statement on the matter. [43393/19]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Medicinal Products Reimbursement
xml · EN · 22 October 2019
Sponsors
- Micheál Martin · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-10-22/389/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-10-22/pq_389
- ireland · q-2019-10-22-pq_389 · source updated 22 October 2019